Ascentage Has First U.S. Biotech IPO of 2025, Raising $126M to Bring Its Cancer Meds to the World
Ascentage Pharma, a China-based drug developer with global ambitions, now has $126.4 million from a U.S. IPO that will mainly ...
Ascentage Pharma, a China-based drug developer with global ambitions, now has $126.4 million from a U.S. IPO that will mainly ...
Last update: 20.01.2025 | 11:50 Related topics: Mandy Damari, the mother of Emily Damari who was returned from Hamas captivity ...
One of the most lasting images of late November 2023 — alongside tearful photos of freed Israeli hostages reuniting with ...
The View’s Joy Behar gave an ode to President Joe Biden on ABC’s Thursday program after his farewell address to ...
From Parshat Bereishit, which describes the creation of the world in six days, we learn that God did not ...
Shohei Ohtani's 50/50 HR Ball Makes a Record-Breaking Sale Shohei Ohtani, the superstar of the Los Angeles Dodgers, has been ...
As the Jewish High Holidays approach, it's a good time to reflect on the significant decisions made by Jewish athletes ...
French actor Gérard Depardieu is in police custody as investigators probe two separate allegations of sexual assault by two women ...
A U.S. Federal Reserve meeting and Apple and Amazon reporting results will keep investors' focus in the days ahead on ...
The 48 Hours When Joe Biden Saved Us From World War III We at the Washington Monthly may have published our Presidential Accomplishment ...
Copyright © 2024 The Israel Chronicle News.
The Israel Chronicle News is not responsible for the content of external sites.